Leidos
LDOS
$124.84
+0.93%
Leidos Holdings, Inc. is a major technology, engineering, and science company providing services and solutions primarily to U.S. government agencies in defense, intelligence, civil, and health sectors. The company operates as a leading government IT services contractor, distinguished by its scale and diversified portfolio across four reportable segments including National Security & Digital and Health & Civil. The current investor narrative is dominated by a sharp stock price decline following a quarterly earnings report where record profits were overshadowed by a revenue miss and cautious guidance, coupled with concerns over potential government budget disruptions and emerging competitive threats from private-sector innovators in autonomous defense systems.…
LDOS
Leidos
$124.84
Related headlines
Investment Opinion: Should I buy LDOS Today?
Rating: Hold. The core thesis is that Leidos presents a classic 'value trap' scenario—deeply undervalued on earnings but facing genuine and worsening fundamental headwinds that justify the market's skepticism.
Supporting this view, the forward P/E of 9.4x is exceptionally low for a profitable IT services firm, and the Price/Sales ratio of 1.41x sits at a discount to the industry. However, these valuation metrics are offset by negative revenue growth of -3.6% YoY, gross margin compression of 240 bps sequentially, and a stock price that has severely underperformed the market (relative strength of -38.3 over 3 months). The company's robust free cash flow generation ($1.625B TTM) and high ROE (29.6%) are positive, but they are currently being overshadowed by the top-line contraction.
The thesis would upgrade to a Buy if quarterly revenue growth returns to positive territory and gross margins stabilize above 17%, signaling the operational decline has bottomed. It would downgrade to a Sell if revenue decline accelerates beyond -5% YoY or if the forward P/E expands above 12x without corresponding earnings growth, eliminating the valuation cushion. Relative to its own history and the sector's growth challenges, the stock is fairly valued—the low multiple accurately reflects the elevated execution and competitive risks.
Sign up to view all
LDOS 12-Month Price Forecast
The investment case for LDOS is balanced between deep value and deteriorating fundamentals. The severe price decline has created a valuation cushion, with the stock trading at a forward P/E that prices in stagnation. However, the recent negative revenue growth and margin compression are concrete red flags that cannot be ignored. The base case is a prolonged period of sideways trading as the company works to stabilize its operations, with the dividend and cash flow providing downside support. The stance would turn bullish on evidence of revenue stabilization and margin recovery, likely requiring two consecutive quarters of improved performance. It would turn bearish if the next earnings report shows an acceleration in the revenue decline or further gross margin erosion below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Leidos's 12-month outlook, with a consensus price target around $162.29 and implied upside of +30.0% versus the current price.
Average Target
$162.29
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$100 - $162
Analyst target range
A cohort of 8 analysts provides coverage for Leidos, indicating solid institutional interest. The consensus sentiment appears mixed-to-cautious, as evidenced by recent institutional rating actions including a downgrade from Stifel (from Buy to Hold) in January 2026, alongside maintains of Neutral and Outperform ratings from other firms. The average target price is not explicitly provided in the data, but analyst EPS estimates offer a proxy for expectations, with an average estimate of $14.45, a low of $12.93, and a high of $15.72, implying a range of potential outcomes. The wide spread between the low and high EPS estimates signals significant uncertainty among analysts regarding the company's near-term earnings power, which is consistent with the stock's high volatility and recent guidance-related sell-off. This uncertainty, coupled with the recent downgrade, suggests analyst conviction is currently weak, and the stock may lack near-term catalysts until visibility on revenue growth and margin trajectory improves.
Bulls vs Bears: LDOS Investment Factors
The bear case currently holds stronger evidence, driven by concrete negative fundamentals: revenue contraction, margin compression, and a cautious outlook that triggered a severe 35% six-month stock decline. The bull case rests primarily on a deeply discounted valuation (9.4x forward P/E) and strong cash generation, suggesting the bad news is largely priced in. The single most important tension in the investment debate is whether the recent revenue decline and margin pressure are temporary execution issues within a stable government contracting model, or the beginning of a sustained downtrend due to budget pressures and competitive disruption. The resolution of this tension, visible in future quarterly revenue growth and gross margin figures, will determine if the stock is a value trap or a deep-value opportunity.
Bullish
- Deeply Undervalued Forward P/E: The stock trades at a forward P/E of 9.4x based on consensus EPS of $14.45, representing a significant discount to its own trailing P/E of 16.7x and typical IT services valuations. This low multiple implies the market is pricing in minimal growth, creating a potential margin of safety.
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $1.625 billion, supporting shareholder returns and financial flexibility. This strong cash generation underpins the 0.87% dividend yield and provides a buffer against operational headwinds.
- High Return on Equity: Leidos maintains a high Return on Equity of 29.6%, indicating efficient use of shareholder capital and a profitable business model. This metric, even under pressure, remains well above industry averages for capital-intensive contractors.
- Oversold Technical Condition: The stock is down 35.4% over six months and trades near its 52-week low of $121.53, a level representing a 40% drawdown from its high. This extreme negative momentum, coupled with a low beta of 0.57, suggests the sell-off may be overdone relative to the company's underlying risk profile.
Bearish
- Revenue Contraction and Weak Outlook: Q4 2025 revenue declined 3.6% YoY to $4.21B, and the sequential decline from Q3's $4.47B indicates a worsening trend. The recent guidance cut and focus on a 'weak outlook' by investors signal fundamental deterioration in the core government contracting business.
- Severe Gross Margin Compression: Gross margin collapsed to 16% in Q4 2025 from 18.4% in Q3 2025, a 240 basis point sequential contraction. This indicates significant pricing pressure or cost inflation that is eroding profitability despite record net income in the quarter.
- Analyst Downgrades and High Uncertainty: Analyst conviction is weak, evidenced by a recent downgrade from Stifel (Buy to Hold) and a wide EPS estimate range of $12.93-$15.72. This uncertainty reflects concerns over government budget disruptions and the company's ability to meet forward earnings expectations.
- Competitive Disruption from Innovators: News highlights emerging threats from private-sector innovators like Saronic in autonomous defense systems, which could disrupt traditional contracting models. This represents a structural risk to Leidos's long-term growth narrative in its core National Security segment.
LDOS Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -21.10% and a more severe 6-month decline of -35.38%. As of the latest close at $123.69, the price is trading near the bottom of its 52-week range, positioned at approximately 60% of the span from the $121.53 low to the $205.77 high, indicating the stock is deeply oversold and may represent a value opportunity, though it risks being a 'falling knife' without a clear catalyst. Recent momentum has been sharply negative and accelerating, with the stock down 22.23% over the past month and 29.84% over three months, a severe divergence from the broader market's positive performance (SPY +5.6% and +8.42% over the same periods) as shown by relative strength figures of -27.83 and -38.26. This intense selling pressure suggests a fundamental re-rating rather than a temporary pullback, with no technical support from momentum indicators. Key technical levels are clearly defined, with immediate support at the 52-week low of $121.53 and major resistance at the 52-week high of $205.77. A breakdown below the $121.53 support could trigger further algorithmic selling, while any recovery would face a formidable wall of overhead supply. The stock's beta of 0.57 indicates it has been significantly less volatile than the market, which is unusual given the recent price collapse and suggests the downdraft has been driven by stock-specific news rather than sector-wide risk-off sentiment.
Beta
0.57
0.57x market volatility
Max Drawdown
-38.0%
Largest decline past year
52-Week Range
$122-$206
Price range past year
Annual Return
-21.5%
Cumulative gain past year
| Period | LDOS Return | S&P 500 |
|---|---|---|
| 1m | -19.5% | +4.0% |
| 3m | -22.7% | +8.2% |
| 6m | -34.0% | +11.5% |
| 1y | -21.5% | +24.3% |
| ytd | -32.0% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LDOS Fundamental Analysis
Revenue growth has stalled and turned negative recently, with Q4 2025 revenue of $4.21 billion representing a -3.6% year-over-year decline, and a sequential drop from Q3's $4.47 billion. Segment data shows the National Security Solutions segment is the largest contributor at $5.02 billion, but the overall multi-quarter trend indicates growth deceleration, casting doubt on near-term momentum for this government-dependent business. The company remains profitable with a net income of $335 million in the latest quarter, but profitability metrics show pressure; the gross margin of 16% in Q4 2025 is down from 18.4% in Q3 2025, and the net margin of 7.96% has compressed from 8.21% the prior quarter, indicating some cost inefficiencies or competitive pricing pressures. The balance sheet and cash flow picture is mixed: the company maintains a solid current ratio of 1.70 and generates substantial free cash flow (TTM FCF of $1.625 billion), supporting shareholder returns. However, the debt-to-equity ratio of 1.21 indicates a leveraged capital structure, though this is manageable given the stable government contracting business model. The Return on Equity of 29.6% is robust, signaling efficient use of shareholder capital, but the sustainability of this high ROE is questionable if revenue and margin pressures persist.
Quarterly Revenue
$4.2B
2026-01
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LDOS Overvalued?
Given Net Income is positive ($335M in latest quarter), the primary valuation metric is the P/E ratio. The trailing P/E is 16.69x, while the forward P/E is significantly lower at 9.40x, indicating the market expects a significant recovery in earnings, likely based on analyst EPS estimates averaging $14.45 for the coming year. The large gap between trailing and forward multiples reflects both depressed current earnings and optimistic future projections. Compared to industry averages, Leidos trades at a discount on a Price/Sales basis, with a PS ratio of 1.41x; typical IT services firms often trade above 2x sales, suggesting the market is applying a penalty due to the company's growth challenges and government exposure. This discount may be justified given the recent revenue contraction and uncertain outlook, but it also presents a potential value opportunity if the company can stabilize its top line. Historically, the stock's own valuation has compressed dramatically; its current trailing P/E of 16.69x is below the 18.13x from the end of Q4 2025 and far below levels seen in prior quarters (e.g., 17.04x in Q3 2025). Trading near the lower end of its own historical valuation band suggests much of the negative news is priced in, but also reflects genuine fundamental deterioration rather than mere multiple contraction.
PE
16.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -8x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on deteriorating fundamentals and leverage. Revenue declined 3.6% YoY in Q4 2025, reversing prior growth and raising questions about the sustainability of the business model. Gross margin compression from 18.4% to 16% quarter-over-quarter indicates rising costs or competitive pressures that could further impair profitability. While the debt-to-equity ratio of 1.21 is manageable, a continued revenue slump could strain cash flow needed to service this debt, especially if the company maintains its dividend and share buybacks.
Market & Competitive Risks are heightened by valuation compression and disruptive threats. The stock's Price/Sales ratio of 1.41x trades at a discount to IT services peers, but this discount could persist or widen if growth remains negative. The beta of 0.57 suggests low market correlation, but the stock's own 38% maximum drawdown shows it carries significant idiosyncratic risk. Recent news about private companies like Saronic innovating in autonomous defense systems poses a long-term threat to Leidos's traditional government contracting moat, potentially accelerating market share loss.
Worst-Case Scenario involves a continuation of the current downtrend triggered by a government budget impasse, leading to contract delays and cancellations. This could cause revenue to miss already lowered estimates and margins to compress further, prompting multiple analyst downgrades and a re-rating to a distressed valuation. In this adverse scenario, the stock could realistically test and break below its 52-week low of $121.53, implying a further -2% decline from the current $123.69. A more severe bear case, aligning with the stock's 38% historical max drawdown, could see a fall to approximately $76, representing a -39% downside from current levels if sentiment completely evaporates.
FAQ
The key risks are, in order of severity: 1) Operational Deterioration Risk: Continued revenue decline and margin compression, as evidenced by the -3.6% YoY revenue drop and 240 bps sequential gross margin contraction in Q4 2025. 2) Government Budget Risk: Dependence on U.S. federal spending makes the company vulnerable to political gridlock, shutdowns, and shifting budget priorities. 3) Competitive Disruption Risk: Emerging threats from agile private-sector innovators like Saronic in autonomous systems could erode Leidos's moat in its core defense contracts. 4) Sentiment & Technical Risk: The stock is in a severe downtrend, down 35% in six months, and breaking below the $121.53 support could trigger further algorithmic and institutional selling.
Our 12-month outlook outlines three scenarios. The Base Case (55% probability) sees the stock trading between $130 and $150, as the company stabilizes but fails to reignite growth, meeting the low end of analyst EPS estimates. The Bull Case (25% probability) projects a range of $155 to $175, driven by a return to revenue growth, margin recovery, and a valuation re-rating. The Bear Case (20% probability) warns of a drop to $105-$125 if operational deterioration accelerates. The base case is most likely, anchored by the analyst EPS consensus of $14.45 and the current forward P/E of 9.4x. The key assumption is that revenue growth remains flat to slightly negative, preventing any meaningful multiple expansion in the near term.
LDOS appears statistically undervalued based on earnings, but the discount may be justified by its deteriorating fundamentals. The forward P/E of 9.4x is low compared to historical levels and the broader market, and the Price/Sales ratio of 1.41x is a discount to many IT services peers. However, this valuation implies the market expects minimal growth or even contraction, which is consistent with the recent -3.6% YoY revenue decline. Therefore, the stock is fairly valued relative to its near-term prospects. It is not cheap enough to be a clear-value buy without a growth catalyst, nor is it expensive enough to short given its strong cash flow. The market is pricing in a stagnant, no-growth scenario, which seems appropriate given current data.
LDOS presents a high-risk, high-potential-reward opportunity that is not suitable for all investors. For value investors with a long-term horizon and high risk tolerance, the current forward P/E of 9.4x and Price/Sales of 1.41x may represent a compelling entry point, assuming the company's operational issues are temporary. However, the recent -3.6% YoY revenue decline and gross margin compression are serious fundamental red flags. The stock is a good buy only for those who have done deep due diligence and believe the government contracting business will stabilize, and who are prepared to average down if the price falls further. For most investors, it is prudent to wait for concrete evidence of a turnaround in the form of at least one quarter of sequential revenue and margin improvement.
LDOS is unsuitable for short-term trading due to its high volatility (down 22% in the past month) and lack of near-term positive catalysts. The stock's low beta of 0.57 is misleading given its recent stock-specific crash. It is better suited for long-term, patient investors willing to wait 2-3 years for a potential turnaround. The company's stable government clientele and strong free cash flow generation support a long-term holding thesis, but investors must be prepared for significant price swings and a potentially lengthy period of consolidation. The 0.87% dividend yield provides a minor income component but is not sufficient to justify ownership on its own. A minimum holding period of 18-24 months is suggested to allow time for operational improvements to materialize and be recognized by the market.
